Prelude Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Buy |
20,000
+8,300
| +71% | +$162K | 0.04% | 514 |
|
|
2025
Q1 | $208K | Buy |
+11,700
| New | +$208K | 0.02% | 836 |
|
|
2020
Q3 | – | Sell |
-10,502
| Closed | -$372K | – | 1425 |
|
|
2020
Q2 | $372K | Buy |
10,502
+5,582
| +113% | +$198K | 0.02% | 353 |
|
|
2020
Q1 | $107K | Sell |
4,920
-11,888
| -71% | -$259K | 0.01% | 345 |
|
|
2019
Q4 | $363K | Sell |
16,808
-2,043
| -11% | -$44.1K | 0.01% | 386 |
|
|
2019
Q3 | $426K | Sell |
18,851
-11,067
| -37% | -$250K | 0.02% | 306 |
|
|
2019
Q2 | $1.08M | Buy |
29,918
+11,211
| +60% | +$404K | 0.05% | 166 |
|
|
2019
Q1 | $590K | Buy |
18,707
+11,037
| +144% | +$348K | 0.03% | 254 |
|
|
2018
Q4 | $193K | Sell |
7,670
-400
| -5% | -$10.1K | 0.01% | 514 |
|
|
2018
Q3 | $233K | Sell |
8,070
-28,550
| -78% | -$824K | 0.01% | 498 |
|
|
2018
Q2 | $448K | Buy |
36,620
+1,500
| +4% | +$18.4K | 0.03% | 435 |
|
|
2018
Q1 | $280K | Buy |
35,120
+9,600
| +38% | +$76.5K | 0.02% | 529 |
|
|
2017
Q4 | $187K | Buy |
+25,520
| New | +$187K | 0.02% | 552 |
|